Krankheiten im Onco Wiki
OpenOnco coverage across 103 oncology diagnoses: biomarkers, drugs, indications/regimens/RedFlags, algorithm and questionnaire presence, fill and optional recorded content-review evidence.
Begriffsbestimmungen für die Metrische Medizin
- == Einzelnachweise == — verschiedene Biomarker, die durch die Indikationen + Regimen dieser Krankheit referenziert werden
- ♪ Drug — verschiedene Medikamente in den Therapien dieser Krankheit
- #Ind / #Reg / #RF — Indikationen / Regimen / RedFlags für diese Krankheit
- 1L / 2L — Algorithm presence for first-line / second-line+
- Aufgaben — ✓ hand-authored / STUB auto-generated / — absent
- Füllen % — zusammengesetzte über 8 Entitätstypen: ≥1 Indikation, ≥1 Therapie, ≥ 1 Biomarker, ≥1-Arzneimittel, ≥1/Redflag, 1L Algo, Fragebogen, Untersuchung
- Ver % — % of this disease's indications with reviewer_signoffs ≥ 2 (CHARTER §6.1)
Einzelprojekt. Eine verantwortliche Person veröffentlicht Aktualisierungen mit automatisierten Prüfungen und nachvollziehbaren Quellen. Externe klinische Prüfungen sind optional und werden gesondert dokumentiert.
Krankheiten insgesamt
103
Avg füllen
69.8%
Mit 1L Algorithmus
87/103
Mit 2L+ Algorithmus
55/103
103
Keine Krankheiten entsprechen Ihrer Suche.
Krankheitsumfang
Lymphoidhämatologisch (28)
| Erkrankung | ICD-10 | Bio | Arzneimittel | Ind | Verordnung | RF | 1L | 2L | Aufgaben | Füllen % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATLL Adulte T-Zell-Leukämie/Lymphom | C91.5 | 1 | 9 | 5 | 3 | 8 | ✓ | ✓ | — | 88% | 0% |
| ALCL Anaplastisches Großzell-Lymphom, systemisch | C84.6 | 2 | 6 | 5 | 5 | 5 | ✓ | ✓ | — | 88% | 0% |
| AITL Angioimmunoblastisches T-Zell-Lymphom | C84.4 | 2 | 9 | 5 | 5 | 8 | ✓ | ✓ | — | 88% | 0% |
| B-ALL B-Lymphoblastische Leukämie/Lymphom | C91.0 | 1 | 14 | 8 | 5 | 9 | ✓ | ✓ | — | 88% | 0% |
| BURKITT Burkitt Lymphom | C83.7 | 3 | 15 | 10 | 6 | 10 | ✓ | ✓ | — | 88% | 0% |
| CLL Chronische Lymphozyten-Leukämie / Kleine Lymphozyte Lymphom | C91.1 | 5 | 7 | 8 | 6 | 13 | ✓ | ✓ | ✓ | 88% | 0% |
| CHL Klassisches Hodgkin Lymphom | C81.9 | 3 | 7 | 7 | 5 | 6 | ✓ | ✓ | — | 88% | 0% |
| DLBCL-NOS Diffuses großzelliges B-Zell-Lymphom, nicht näher spezifiziert | C83.3 | 8 | 15 | 26 | 10 | 23 | ✓ | ✓ | — | 88% | 0% |
| NK-T-NASAL Extranodales NK/T-Zell-Lymphom, Nasentyp | C86.0 | 1 | 8 | 3 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| FL Follicular Lymphom | C82.0 | 3 | 12 | 9 | 8 | 9 | ✓ | ✓ | — | 88% | 0% |
| HCV-MZL HCV-assoziiertes Marginalzonenlymphom | C88.4 | 1 | 3 | 7 | 3 | 7 | ✓ | ✓ | ✓ | 88% | 0% |
| HGBL-DH Hochgradiges B-Zell-Lymphom, Double-Hit / Triple-Hit | C83.3 | 5 | 8 | 3 | 3 | 7 | ✓ | ✓ | — | 88% | 0% |
| MCL Mantelzell-Lymphom | C83.1 | 5 | 12 | 7 | 6 | 9 | ✓ | ✓ | — | 88% | 0% |
| MM Multiples Myelom | C90.0 | 2 | 13 | 16 | 13 | 14 | ✓ | ✓ | ✓ | 88% | 0% |
| MF-SEZARY Mykose-Fungoide / Sézary-Syndrom | C84.0 | 1 | 3 | 5 | 4 | 5 | ✓ | ✓ | — | 88% | 0% |
| NODAL-MZL Nodales Randzonenlymphom | C83.0 | 3 | 3 | 4 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| NLPBL Noduläres Lymphozyten-Prädominant B-Zell-Lymphom | C81.0 | 1 | 5 | 3 | 2 | 6 | ✓ | ✓ | — | 88% | 0% |
| PTLD Nach Transplantation Erkrankungen der Lymphproliferative Erkrankungen | D47.Z1 | 3 | 5 | 3 | 3 | 6 | ✓ | ✓ | — | 88% | 0% |
| PCNSL Primäres ZNS Lymphom | C85.7 | 1 | 6 | 3 | 3 | 6 | ✓ | ✓ | — | 88% | 0% |
| PMBCL Primäres Mediastinal-Großes B-Zell-Lymphom | C85.2 | 1 | 8 | 3 | 3 | 8 | ✓ | ✓ | — | 88% | 0% |
| SPLENIC-MZL Milzrandzonenlymphom | C83.0 | 3 | 3 | 3 | 3 | 5 | ✓ | ✓ | — | 88% | 0% |
| T-PLL T-Zell-Prolymphocytische Leukämie | C91.6 | 1 | 2 | 2 | 2 | 5 | ✓ | ✓ | — | 88% | 0% |
| WM Waldenström Makroglobulinämie / Lymphoplasmacytikum | C88.0 | 2 | 6 | 5 | 5 | 7 | ✓ | ✓ | — | 88% | 0% |
| EATL Enteropathie-assoziiertes T-Zell-Lymphom | C86.2 | 0 | 7 | 4 | 2 | 6 | ✓ | — | — | 75% | 0% |
| HCL Haarzellenleukämie | C91.4 | 0 | 2 | 3 | 2 | 5 | ✓ | ✓ | — | 75% | 0% |
| HSTCL Hepatosplenic T-Cell Lymphoma | C84.7 | 0 | 7 | 2 | 2 | 6 | ✓ | — | — | 75% | 0% |
| PTCL-NOS Peripheres T-Zell-Lymphom, NOS | C84.4 | 0 | 8 | 4 | 4 | 5 | ✓ | ✓ | — | 75% | 0% |
| T-ALL T-Lymphoblastische Leukämie/Lymphom | C91.0 | 0 | 9 | 2 | 2 | 9 | ✓ | ✓ | — | 75% | 0% |
| avg | 85.7% | 0.0% | |||||||||
Myeloische Hämatologie (9)
| Erkrankung | ICD-10 | Bio | Arzneimittel | Ind | Verordnung | RF | 1L | 2L | Aufgaben | Füllen % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AML Akute myeloische Leukämie | C92.0 | 4 | 13 | 39 | 10 | 37 | ✓ | ✓ | — | 88% | 0% |
| MASTOCYTOSIS Fortgeschrittene systemische Mastozytose | C96.2, D47.09 | 1 | 2 | 2 | 2 | 6 | ✓ | — | — | 88% | 0% |
| PV Polyzytämie Vera | D45 | 1 | 5 | 6 | 4 | 6 | ✓ | ✓ | — | 88% | 0% |
| APL Akute promyelocytische Leukämie | C92.4 | 0 | 4 | 4 | 4 | 9 | ✓ | ✓ | — | 75% | 0% |
| CML Chronische Myeloide Leukämie | C92.1 | 0 | 7 | 5 | 5 | 9 | ✓ | ✓ | — | 75% | 0% |
| ET Wesentliche Thrombozytämie | D47.3 | 0 | 3 | 3 | 2 | 7 | ✓ | ✓ | — | 75% | 0% |
| MDS-HR Myelodysplastische Syndrome — höheres Risiko | D46.2 | 0 | 2 | 7 | 3 | 15 | ✓ | ✓ | — | 75% | 0% |
| MDS-LR Myelodysplastische Syndrome — geringeres Risiko | D46.9 | 0 | 4 | 4 | 4 | 9 | ✓ | ✓ | — | 75% | 0% |
| PMF Primäre Myelofibrosis | D47.4 | 0 | 3 | 5 | 4 | 7 | ✓ | ✓ | — | 75% | 0% |
| avg | 79.3% | 0.0% | |||||||||
Feste Tumoren (66)
| Erkrankung | ICD-10 | Bio | Arzneimittel | Ind | Verordnung | RF | 1L | 2L | Aufgaben | Füllen % | Ver % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| THYROID-ANAPLASTIC Anaplastisches Schilddrüsenkarzinom | C73 | 1 | 4 | 2 | 2 | 7 | ✓ | — | — | 88% | 0% |
| BCC Basalzellkarzinom | C44 | 2 | 2 | 4 | 2 | 8 | ✓ | — | — | 88% | 0% |
| CERVICAL Zervikales Karzinom | C53 | 2 | 7 | 9 | 4 | 17 | ✓ | — | — | 88% | 0% |
| CHOLANGIOCARCINOMA Cholangiokarzinom | C22.1, C24.0 | 3 | 9 | 12 | 8 | 10 | ✓ | ✓ | — | 88% | 0% |
| CRC Kolorektales Karzinom | C18-C20 | 5 | 16 | 75 | 15 | 43 | ✓ | ✓ | — | 88% | 0% |
| MELANOMA Hautmelanom | C43 | 2 | 12 | 15 | 8 | 19 | ✓ | ✓ | — | 88% | 0% |
| ENDOMETRIAL Endometriumkarzinom | C54 | 2 | 5 | 9 | 4 | 23 | ✓ | ✓ | — | 88% | 0% |
| ESOPHAGEAL Esophagealkarzinom | C15 | 3 | 13 | 19 | 10 | 15 | ✓ | ✓ | — | 88% | 0% |
| GI-NET Neuroendokriner Tumor (Karzinoid) | C17.9 | 1 | 1 | 1 | 1 | 6 | ✓ | — | — | 88% | 0% |
| GASTRIC Magen- und gastroösophageale Kreuzung Adenokarzinom | C16 | 5 | 18 | 19 | 9 | 25 | ✓ | ✓ | — | 88% | 0% |
| GIST Gastrointestinaler Stromatumor | C49 | 2 | 4 | 4 | 4 | 6 | ✓ | ✓ | — | 88% | 0% |
| GBM Glioblastom | C71 | 2 | 2 | 6 | 4 | 8 | ✓ | ✓ | — | 88% | 0% |
| HNSCC Kopf-Hals- Plattenepithelkarzinom | C00-C14, C30-C32 | 1 | 6 | 9 | 5 | 9 | ✓ | ✓ | — | 88% | 0% |
| HCC Leberzelluläres Karzinom | C22.0 | 4 | 10 | 32 | 8 | 23 | ✓ | ✓ | — | 88% | 0% |
| IFS Infantiles Fibrosarkom | C49 | 1 | 1 | 1 | 1 | 5 | ✓ | — | — | 88% | 0% |
| IMT Entzündungs-Myofibroblast-Tumor | D48.1 | 1 | 1 | 1 | 1 | 5 | ✓ | — | — | 88% | 0% |
| BREAST Invasives Mammakarzinom | C50 | 11 | 26 | 84 | 19 | 65 | ✓ | ✓ | — | 88% | 0% |
| GLIOMA-LOW-GRADE Niedriggradiges Gliom | C71 | 1 | 3 | 9 | 1 | 11 | ✓ | — | — | 88% | 0% |
| LAM Lymphangioleiomyomatose | J84.81 | 1 | 1 | 1 | 1 | 1 | ✓ | — | — | 88% | 0% |
| MTC Schilddrüsenkarzinom | C73 | 1 | 2 | 6 | 2 | 8 | ✓ | — | — | 88% | 0% |
| NSCLC Nicht-kleinzelliges Lungenkarzinom | C34 | 19 | 32 | 77 | 30 | 44 | ✓ | ✓ | — | 88% | 0% |
| OVARIAN Ovarialkarzinom | C56 | 4 | 11 | 25 | 11 | 34 | ✓ | ✓ | — | 88% | 0% |
| PDAC Duktales Adenokarzinom des Pankreas | C25 | 1 | 9 | 18 | 5 | 36 | ✓ | ✓ | — | 88% | 0% |
| PNET Pankreas-Neuroendokrin-Tumor | C25.4 | 1 | 1 | 7 | 1 | 5 | ✓ | — | — | 88% | 0% |
| PROSTATE Adenokarzinom der Prostata | C61 | 4 | 10 | 9 | 8 | 27 | ✓ | ✓ | — | 88% | 0% |
| RCC Nierenzellkarzinom | C64 | 1 | 7 | 27 | 7 | 23 | ✓ | ✓ | — | 88% | 0% |
| UROTHELIAL Urothelkarzinom | C67 | 1 | 6 | 16 | 6 | 20 | ✓ | ✓ | — | 88% | 0% |
| GRANULOSA-CELL Erwachsener Granulosa-Zelltumor | C56 | 1 | 2 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| ANAL-SCC Anales Plattenepithelkarzinom (Anal SCC) | C21.0 | 0 | 5 | 3 | 3 | 2 | ✓ | — | — | 75% | 0% |
| CHONDROSARCOMA Chondrosarkom | C40, C41 | 0 | 1 | 1 | 1 | 5 | ✓ | — | — | 75% | 0% |
| EPITHELIOID-SARCOMA Epithelsarkom | C49 | 1 | 1 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| KAPOSI Kaposi-Sarkom | C46 | 1 | 4 | 11 | 4 | 4 | ✓ | — | — | 75% | 0% |
| LARYNGEAL Laryngeal Plattenepithelkarzinom | C32 | 1 | 5 | 7 | 4 | 1 | ✓ | — | — | 75% | 0% |
| MESOTHELIOMA Malignes Mesotheliom | C45.0 | 0 | 4 | 5 | 3 | 5 | ✓ | ✓ | — | 75% | 0% |
| MPNST bösartiger peripherer Nervenscheidentumor | C47 | 0 | 2 | 1 | 1 | 6 | ✓ | — | — | 75% | 0% |
| THYROID-PAPILLARY Papillarschilddrüsenkarzinom | C73 | 0 | 1 | 3 | 1 | 10 | ✓ | — | — | 75% | 0% |
| PARATHYROID-CARCINOMA Nebenschilddrüsenkarzinom | C75.0 | 2 | 2 | 3 | 2 | 1 | ✓ | — | — | 75% | 0% |
| PENILE-SCC Penis Plattenepithelkarzinom | C60 | 1 | 5 | 5 | 3 | 1 | ✓ | — | — | 75% | 0% |
| PITUITARY-ADENOMA Adenom der Hypophyse | D35.2 | 1 | 3 | 4 | 3 | 1 | ✓ | — | — | 75% | 0% |
| SALIVARY Speicheldrüsenkarzinom | C07, C08 | 0 | 2 | 1 | 1 | 6 | ✓ | — | — | 75% | 0% |
| SCLC Kleinzelliges Lungenkarzinom | C34 | 0 | 7 | 7 | 7 | 16 | ✓ | ✓ | — | 75% | 0% |
| SOFT-TISSUE-SARCOMA Weichteilsarkom | C49.9 | 0 | 6 | 10 | 4 | 8 | ✓ | ✓ | — | 75% | 0% |
| TGCT Tenosynovialer Riesenzelltumor | M12.2 | 1 | 1 | 1 | 1 | 0 | ✓ | — | — | 75% | 0% |
| TESTICULAR-GCT Hodenkeimzelltumor | C62.9 | 2 | 5 | 4 | 3 | 0 | ✓ | ✓ | — | 75% | 0% |
| VULVAR-VAGINAL-SCC Vulvar und vaginales Plattenepithelkarzinom | C51, C52 | 1 | 2 | 5 | 2 | 3 | ✓ | — | — | 75% | 0% |
| ADRENOCORTICAL-CARCINOMA Nebennierenrindenkarzinom | C74.0 | 0 | 4 | 2 | 2 | 2 | ✓ | — | — | 62% | 0% |
| NPC Nasopharyngealkarzinom | C11 | 0 | 3 | 2 | 2 | 1 | ✓ | — | — | 62% | 0% |
| PHEOCHROMOCYTOMA Pheochromozytom | D35.0 | 0 | 4 | 14 | 4 | 9 | ✓ | — | — | 62% | 0% |
| JMML Juvenil myelomonozytäre Leukämie | C93.3 | 0 | 0 | 1 | 1 | 0 | ✓ | — | — | 50% | 0% |
| MENINGIOMA Meningiom | D32 | 0 | 0 | 1 | 0 | 1 | ✓ | — | — | 50% | 0% |
| OSTEOSARCOMA Osteosarkom | C40, C41 | 0 | 0 | 2 | 0 | 4 | — | — | — | 25% | 0% |
| WILMS Wilms Tumor | C64 | 0 | 0 | 2 | 0 | 2 | — | — | — | 25% | 0% |
| LEIOMYOSARCOMA Leiomyosarkom | C49, C54.2 | 0 | 0 | 0 | 0 | 2 | — | — | — | 12% | 0% |
| ATRT Atypischer Teratoid/Rhabdoid-Tumor | C71.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| CHOROID-PLEXUS-CARCINOMA Karzinom des Choroidplexus | C71.5 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| CYSTIC-NEPHROMA Zystisches Nephrom | D30.0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| HEPATOBLASTOMA Leber- und Gallenerkrankungen | C22.2 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| MEDULLOBLASTOMA Medulloblastom | C71.6 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| NEUROBLASTOMA Neuroblastom | C74.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PARAGANGLIOMA Paragangliom | D44.7 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PINEOBLASTOMA Kieferoblastom | C75.3 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PITUITARY-BLASTOMA Brustblättriges Blastom | C75.1 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| PLEUROPULMONARY-BLASTOMA Pleuropulmonales Blastom | C34 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| RETINOBLASTOMA Retinoblastom | C69.2 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| RHABDOMYOSARCOMA Rhabdomyosarkom | C49.9 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| SERTOLI-LEYDIG-OVARIAN Sertoli-Leydig-Zelltumor | C56 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0% | 0% |
| avg | 61.7% | 0.0% | |||||||||